Page last updated: 2024-11-08

calcium pantothenate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID443753
CHEMBL ID1901349
CHEBI ID31345
SCHEMBL ID34427
MeSH IDM0015822

Synonyms (103)

Synonym
nsc 36292
calcium, bis(pantothenato)-
calpan
calcium n-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-beta-alanine (1:2), (r)-
ccris 1338
calcium pantothenate (van)
n-(2,4-dihydroxy-3,3-dimethylbutyryl)-beta-alanine calcium
calcium pantothenate , d-form
beta-alanine, n-((2r)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, calcium salt (2:1)
pantothenic acid, calcium salt (2:1), d-
pantothenate de calcium [inn-french]
bis(pantothenato)calcium
pantothenic acid, calcium salt (2:1), (+)-
einecs 205-278-9
calcii pantothenas [inn-latin]
calcium d(+)-n-(alpha,gamma-dihydroxy-beta,beta-dimethylbutyryl)-beta-alaninate
beta-alanine, n-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, calcium salt (2:1), (theta)-
pantotenato calcico [inn-spanish]
calcium n-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-beta-alanine
beta-alanine, n-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, calcium salt
beta-alanine, n-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, calcium salt (2:1), (r)-
calcium d-pantothenate (1:2)
calpanate
vitamin b5, calcium salt
pantothenate calcium
nsc-36292
pancal
calcium pantothenate (2:1)
cris pan
pantholin
d-calcium pantothenate
dextro calcium pantothenate
d-calcium pantothenate calcium chloride double salt
calcium panthothenate
ca-hopa
pantothenic acid calcium salt
calcium pantothenate
calcium pantothenate (jp17/usp/inn)
calpan (tn)
D01082
P0012
d-pantothenic acid calcium salt
calcium 3-[[(2r)-2,4-dihydroxy-3,3-dimethyl-butanoyl]amino]propanoate
A807185
pantothenate, calcium
unii-568et80c3d
calcii pantothenas
pantotenato calcico
568et80c3d ,
calcium pantothenate [usp:inn:jan]
pantothenate de calcium
dtxsid8040438 ,
tox21_113437
cas-137-08-6
dtxcid6020438
d-pantothenic acid hemicalcium
calcium pantothenate, d-
pantothenic acid (as calcium)
d-ca pantothenate
calcium pantotenate
CHEMBL1901349
pantothenic acid calcium
calcium pantothenate [vandf]
calcium pantothenate [who-dd]
calcium pantothenate [usp monograph]
.beta.-alanine, n-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, calcium salt (2:1), (r)-
calcium pantothenate [ep monograph]
pantothenic acid calcium salt [mi]
calcium pantothenate [usp-rs]
calcium pantothenate [ep impurity]
calcium pantothenate, (+)-
calcium pantothenate [inn]
pantothenic acid (as calcium pantothenate)
(+)-pantothenic acid calcium salt
pantothenic acid (as calcium) [vandf]
calcium pantothenate [jan]
calcium pantothenate [inci]
FAPWYRCQGJNNSJ-UBKPKTQASA-L
SCHEMBL34427
AKOS024258157
CHEBI:31345
calcium d-(+)-pantothenate
pantothenic acid calcium 10 microg/ml in acetonitrile
AS-13049
D70806
d-pantothenic acid calcium
vitamin b5 calcium salt
Q27261387
d-pantothenicacidhemicalcium
pantotenato calcico (inn-spanish)
calcium pantothenate (usp-rs)
calcium pantothenate (ep monograph)
calcii pantothenas (inn-latin)
a11ha31
calcium pantothenate, d-form
calcium pantothenicum
calcium pantothenate (ep impurity)
calcium pantothenate (usp monograph)
calcium d(+)-n-(alpha,gamma-dihydroxy-beta,beta-dimethylbutyryl)-beta-alaninate calcium, bis(pantothenato)-
monocalcium bis(3-((2r)-2,4-dihydroxy-3,3-dimethylbutanoylamino)propanoate)
d03ax04
pantotenato de calcio
calcio pantotenato

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (135 Items)

ItemProcessFrequency
Beveragescore-ingredient194
Plant-based foods and beveragescore-ingredient134
Plant-based foodscore-ingredient130
Cereals and their productscore-ingredient125
Cereals and potatoescore-ingredient125
Carbonated drinkscore-ingredient85
Sodascore-ingredient79
Breakfast cerealscore-ingredient45
Breakfastscore-ingredient45
Energy drinkscore-ingredient38
Waterscore-ingredient31
Dried productscore-ingredient27
Dehydrated beveragescore-ingredient26
Dried products to be rehydratedcore-ingredient26
Frozen foodscore-ingredient23
Snackscore-ingredient18
Beverages and beverages preparationscore-ingredient17
Meatscore-ingredient15
Meats and their productscore-ingredient15
Energy drink with sugarcore-ingredient14
Sweet snackscore-ingredient13
extruded cerealscore-ingredient13
Sweetened beveragescore-ingredient13
Cakescore-ingredient12
Biscuits and cakescore-ingredient12
Dietary supplementscore-ingredient11
Energy drink without sugar and with artificial sweetenerscore-ingredient10
Frozen meatscore-ingredient8
Artificially sweetened beveragescore-ingredient7
Dietary drink for sportcore-ingredient6
Vitamin waterscore-ingredient6
Eggscore-ingredient5
Farming productscore-ingredient5
Plant-based beveragescore-ingredient4
Carbonated waterscore-ingredient4
en:sweetened-beveragescore-ingredient4
Prepared meatscore-ingredient3
Sandwichescore-ingredient3
Vitaminscore-ingredient3
Cereal grainscore-ingredient3
Seedscore-ingredient3
Céréales et dérivéscore-ingredient3
Céréales et pommes de terrecore-ingredient3
Aliments d'origine végétalecore-ingredient3
Aliments et boissons à base de végétauxcore-ingredient3
Flakescore-ingredient3
Flavored waterscore-ingredient2
Milk substitutescore-ingredient2
Dairy substitutescore-ingredient2
Sausagescore-ingredient2
Meat alternativescore-ingredient2
Dairiescore-ingredient2
Iced teascore-ingredient2
Tea-based beveragescore-ingredient2
Céréales pour petit-déjeunercore-ingredient2
Petit-déjeunerscore-ingredient2
Cereal flakescore-ingredient2
en:Flavored waterscore-ingredient1
en:Carbonated waterscore-ingredient1
en:Spring waterscore-ingredient1
en:Waterscore-ingredient1
en:Carbonated drinkscore-ingredient1
en:Beveragescore-ingredient1
Flavored sparkling waterscore-ingredient1
Creamercore-ingredient1
Chocolate cerealscore-ingredient1
Cocoa powderscore-ingredient1
Cocoa and chocolate powderscore-ingredient1
Cocoa and its productscore-ingredient1
Ricescore-ingredient1
Raisinscore-ingredient1
Dried fruitscore-ingredient1
Dried plant-based foodscore-ingredient1
Fruits based foodscore-ingredient1
Fruits and vegetables based foodscore-ingredient1
Vegan pattiescore-ingredient1
Vegetarian pattiescore-ingredient1
Diet beveragescore-ingredient1
Breakfast cereals rich in fibrecore-ingredient1
Soy-based drinkscore-ingredient1
Legume-based drinkscore-ingredient1
Plant-based milk alternativescore-ingredient1
Legumes and their productscore-ingredient1
en:energy-drink-with-sugarcore-ingredient1
en:open-beauty-factscore-ingredient1
Open Beauty Factscore-ingredient1
Non food productscore-ingredient1
Chicken sandwichescore-ingredient1
Poultry sandwichescore-ingredient1
Stewscore-ingredient1
Mealscore-ingredient1
en:extruded-cerealscore-ingredient1
en:corn-flakescore-ingredient1
Lemonadecore-ingredient1
Egg substitutescore-ingredient1
en:sodascore-ingredient1
energycore-ingredient1
Non-alcoholic beveragescore-ingredient1
Power Drinkcore-ingredient1
Meat analogues from soy or wheat proteinscore-ingredient1
Meat analoguescore-ingredient1
Céréales pour petit déjeuner riches en fibrescore-ingredient1
Corn flakescore-ingredient1
Extruded flakescore-ingredient1
Proteincore-ingredient1
Electrolytescore-ingredient1
Confectioneriescore-ingredient1
Spicescore-ingredient1
Condimentscore-ingredient1
en:artificially-sweetened-beveragescore-ingredient1
en:flavored-waterscore-ingredient1
Fruit-based beveragescore-ingredient1
Unsweetened flavored waterscore-ingredient1
Unsweetened beveragescore-ingredient1
Flavored bottled watercore-ingredient1
Milkscore-ingredient1
Refrigerated plant-based foodscore-ingredient1
Refrigerated foodscore-ingredient1
Chicken nuggetscore-ingredient1
Breaded chickencore-ingredient1
Poultry nuggetscore-ingredient1
Cooked chickencore-ingredient1
Chicken preparationscore-ingredient1
Cooked poultriescore-ingredient1
Chickenscore-ingredient1
Breaded productscore-ingredient1
Poultriescore-ingredient1
Meat preparationscore-ingredient1
Chicken and its productscore-ingredient1
en:vitaminscore-ingredient1
Effervescent tabletcore-ingredient1
Effervescentcore-ingredient1
sans sucre ajoutécore-ingredient1
Boissonscore-ingredient1
Carbonated Sodascore-ingredient1

Drug Classes (1)

ClassDescription
polymerA polymer is a mixture, which is composed of macromolecules of different kinds and which may be differentiated by composition, length, degree of branching etc..
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency11.15280.000221.22318,912.5098AID743036; AID743040; AID743042; AID743053; AID743054
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency5.63670.000214.376460.0339AID720691; AID720719
estrogen nuclear receptor alphaHomo sapiens (human)Potency2.22960.000229.305416,493.5996AID743069; AID743078; AID743080; AID743091
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency7.49780.001723.839378.1014AID743083
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency8.41270.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency8.41270.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (19)

Processvia Protein(s)Taxonomy
coenzyme A biosynthetic processPantothenate kinaseEscherichia coli K-12
coenzyme A biosynthetic processPantothenate kinaseEscherichia coli K-12
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (12)

Processvia Protein(s)Taxonomy
pantothenate kinase activityPantothenate kinaseEscherichia coli K-12
ATP bindingPantothenate kinaseEscherichia coli K-12
kinase activityPantothenate kinaseEscherichia coli K-12
protein homodimerization activityPantothenate kinaseEscherichia coli K-12
pantetheine kinase activityPantothenate kinaseEscherichia coli K-12
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
cytoplasmPantothenate kinaseEscherichia coli K-12
cytoplasmPantothenate kinaseEscherichia coli K-12
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID1152960Activity of purified Escherichia coli pantothenate kinase by spectrophotometry2014Bioorganic & medicinal chemistry, Jun-15, Volume: 22, Issue:12
Exploring structural motifs necessary for substrate binding in the active site of Escherichia coli pantothenate kinase.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID409680Activity of Escherichia coli K12 CoaA2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Antibiotic evaluation and in vivo analysis of alkynyl Coenzyme A antimetabolites in Escherichia coli.
AID409681Ratio of kcat to Km for Escherichia coli K12 CoaA2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Antibiotic evaluation and in vivo analysis of alkynyl Coenzyme A antimetabolites in Escherichia coli.
AID1152961Ratio of kcat to Km for purified Escherichia coli pantothenate kinase by spectrophotometry2014Bioorganic & medicinal chemistry, Jun-15, Volume: 22, Issue:12
Exploring structural motifs necessary for substrate binding in the active site of Escherichia coli pantothenate kinase.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's2 (28.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 78.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index78.22 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index140.92 (26.88)
Search Engine Supply Index2.16 (0.95)

This Compound (78.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]